6161 - 6170 of 6255 Results
Title
Year
-
OPENTitle: TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tauJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 5Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.19809Best OA location URL: https://doi.org/10.7554/elife.19809Citation Count: 122
-
OPENTitle: Varying the rate of intravenous cocaine infusion influences the temporal dynamics of both drug and dopamine concentrations in the striatumJournal Name: European Journal of NeurosciencePublisher: WileyVol: 50Issue #: 3Start Page: 2054End Page: 2064Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ejn.13941Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.13941Citation Count: 20
-
OPENTitle: STEP61is a substrate of the E3 ligase parkin and is upregulated in Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 112Issue #: 4Start Page: 1202End Page: 1207Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1417423112Best OA location URL: https://www.pnas.org/content/pnas/112/4/1202.full.pdfCitation Count: 59
- A Failed Future2020OPENTitle: A Failed FutureJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 8Start Page: 1299End Page: 1301Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28130Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28130Citation Count: 4
- Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteins2018OPENTitle: Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteinsJournal Name: EMBO reportsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/embr.201745680Best OA location URL: https://doi.org/10.15252/embr.201745680Citation Count: 51
-
OPENTitle: A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use as a Therapeutic for Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/364684Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/364684.pdfCitation Count: 17
-
OPENTitle: Valosin-containing-protein pathogenic variant p.R487H in Parkinson’s diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 10Issue #:Start Page: 100236End Page: 100236Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100236Best OA location URL: https://doi.org/10.1016/j.prdoa.2024.100236Citation Count: 0
-
OPENTitle: Parkinson’S Disease is Ready for Precision MedicineJournal Name: Personalized MedicinePublisher: Informa UK LimitedVol: 13Issue #: 5Start Page: 405End Page: 407Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2217/pme-2016-0052Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/pme-2016-0052Citation Count: 7
-
OPENTitle: Dynamic balance and gait impairments in Parkinson’s disease: novel cholinergic patternsJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 6Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.1093/braincomms/fcae286Best OA location URL: https://doi.org/10.1093/braincomms/fcae286Citation Count: 3
-
OPENTitle: CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative BiomarkersJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.834580Best OA location URL: https://doi.org/10.3389/fneur.2022.834580Citation Count: 27